|
KIAA0430 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.631600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.340400E-01 |
| Normal-vs-Stage2 |
8.167900E-02 |
| Normal-vs-Stage3 |
4.275800E-03 |
| Normal-vs-Stage4 |
3.63589999999858E-05 |
| Stage1-vs-Stage2 |
6.700200E-02 |
| Stage1-vs-Stage3 |
1.742730E-03 |
| Stage1-vs-Stage4 |
3.38320000004E-06 |
| Stage2-vs-Stage3 |
6.276200E-01 |
| Stage2-vs-Stage4 |
1.205570E-01 |
| Stage3-vs-Stage4 |
2.288600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.687800E-02 |
| Normal-vs-AfricanAmerican |
3.260200E-03 |
| Normal-vs-Asian |
8.135600E-01 |
| Caucasian-vs-AfricanAmerican |
7.126400E-02 |
| Caucasian-vs-Asian |
5.397800E-01 |
| AfricanAmerican-vs-Asian |
1.590040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.045800E-02 |
| Normal-vs-Female |
1.540160E-01 |
| Male-vs-Female |
5.126400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.055900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.985000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.364070E-02 |
| Normal-vs-Age(81-100Yrs) |
1.255650E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.933010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.343400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.670000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.787600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.040800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.233600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.683770E-01 |
| Normal-vs-Grade 2 |
8.474200E-01 |
| Normal-vs-Grade 3 |
8.483600E-03 |
| Normal-vs-Grade 4 |
1.17050000003616E-06 |
| Grade 1-vs-Grade 2 |
1.559370E-01 |
| Grade 1-vs-Grade 3 |
1.155580E-02 |
| Grade 1-vs-Grade 4 |
1.614720E-04 |
| Grade 2-vs-Grade 3 |
2.623800E-03 |
| Grade 2-vs-Grade 4 |
6.72089999986802E-07 |
| Grade 3-vs-Grade 4 |
5.962300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.574100E-02 |
| Normal-vs-ccB subtype |
1.416930E-04 |
| ccA subtype-vs-ccB subtype |
1.27730004351179E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.730500E-02 |
| Normal-vs-N1 |
3.235500E-02 |
| N0-vs-N1 |
1.312160E-01 |
|
|
